Thomas Jefferson University researchers developed an AutoML model that distinguishes pituitary macroadenomas from parasellar meningiomas on MRI with over 97% accuracy.
Key Details
- 1AutoML model trained to classify pituitary macroadenomas vs. parasellar meningiomas on preoperative MRI.
- 2Achieved 97.55% overall accuracy, with sensitivities of 97% (macroadenoma) and 98.41% (meningioma), and specificities of 98.96% and 95.53%, respectively.
- 3External validation conducted on 959 additional MRI images.
- 4Model allows different confidence thresholds, aiding both community screening and tertiary centers.
- 5First reported use of AutoML for this specific neuro-oncology imaging task.
- 6The study published in Otolaryngology–Head and Neck Surgery (Dec 2025); presented at AAO-HNSF 2025.
Why It Matters
Accurate, non-invasive differentiation of similar-appearing benign brain tumors using MRI can improve preoperative planning, reduce surgical risks, and ensure patients receive optimal treatment. This demonstrates AutoML's potential to streamline diagnostic AI development and deployment in neuro-radiology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.